SCHEMBL13775465

SCHEMBL13775465

OC(c1cc(Cl)ccc1-n1cccc1)c1cccc2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.40
ADRA2A P08913 2/20 0.39
ADRA2B P18089 2/20 0.39
ADRA2C P18825 2/20 0.39
ADRA1D P25100 2/20 0.39
ADRA1A P35348 2/20 0.39
ADRA1B P35368 2/20 0.39
ACP3 P15309 1/20 0.38
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37
TSHR P16473 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36
GAA P10253 1/20 0.35
MEN1 O00255 1/20 0.34
RAB9A P51151 1/20 0.34
KCNA3 P22001 1/20 0.33
MDM2 Q00987 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14146063 0.83 CYP2C9 (0.40) KMT2AACP3CYP2C9CYP2C19HPGD
SCHEMBL13775459 0.81 KCNH2 (0.36) CYP2C9CYP2C19HTTALDH1A1CYP1A2
SCHEMBL4121986 0.77 ADRA2A (0.42) KMT2AADRA2AADRA2BADRA2CADRA1D
SCHEMBL13776051 0.74 KMT2A (0.40) KMT2AADRA2AADRA2BADRA2CADRA1D
SCHEMBL4122542 0.74 ALDH1A1 (0.36) ALDH1A1
SCHEMBL4119389 0.74 CNR1 (0.33) KMT2AALDH1A1GAA
SCHEMBL598905 0.73 ALDH1A1 (0.60) KMT2AADRA2AADRA2BADRA2CADRA1D
SCHEMBL31332147 0.73 ALDH1A1 (0.60) KMT2AADRA2AADRA2BADRA2CADRA1D
SCHEMBL14033098 0.71 ACP3 (0.49) KMT2AADRA2AADRA2BADRA2CADRA1D
SCHEMBL4121438 0.71 MEN1 (0.46) KMT2AACP3ALDH1A1MEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR KMT2A 1467/4885ADRA2A 2797/4885ADRA2B 3507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.